Core Insights - CVS Health reported a decline in fourth-quarter profit but exceeded Wall Street estimates, driven by strength in its pharmacy benefit unit and robust prescription volume at its retail pharmacies [1] Financial Performance - The company experienced a decrease in profit for the fourth quarter, yet managed to outperform analysts' expectations [1] - The performance was bolstered by the pharmacy benefit unit, indicating a strong demand for prescription services [1] Business Segments - The pharmacy benefit unit showed significant strength, contributing positively to the overall performance of CVS Health [1] - Retail pharmacies also reported strong prescription volume, which played a crucial role in the company's ability to beat estimates [1]

US spot Bitcoin exchange-traded funds extended a tentative recovery last week and into early this week, as fresh inflows offered early signs that institutional demand may be stabilising after a prolon... ...

Core Viewpoint - Quest Diagnostics has announced a 7.5% increase in its quarterly cash dividend to $0.86 per share, effective April 20, 2026, with an annual cash dividend totaling $3.44 per share [1] Group 1: Dividend Increase - The Board of Directors has authorized a 7.5% increase in the quarterly cash dividend from $0.80 to $0.86 per share [1] - The increase will be effective for the dividend payable on April 20, 2026, to shareholders of record on April 6, 2026 [1] - The annual cash dividend will now amount to $3.44 per share [1] Group 2: Share Repurchase Authorization - The Board of Directors has increased the Company's share repurchase authorization by $1 billion [2] - This increase is in addition to the approximately $0.4 billion that was available as of December 31, 2025, under the share repurchase program [2] Group 3: Company Overview - Quest Diagnostics is a leading provider of diagnostic information services, connecting clinicians and consumers with laboratory insights [3] - The company serves half of the physicians and hospitals in the United States and one in three American adults each year [3] - Quest Diagnostics employs nearly 57,000 individuals to deliver diagnostic insights that inspire actions to improve health [3]

Hasbro on Tuesday forecast annual revenue below Wall Street estimates, as the toy maker grapples with consumers pushing back on non-essential purchases, including toys, due to economic uncertainty. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Cryptocurrency behemoth Coinbase Global Inc. (NASDAQ:NVDA) is set to release its fourth-quarter financials on Thursday, and cryptocurrency bettors are speculating on a variety of topics that could be mentioned during the earnings call.Stablecoins Dominating Market Predictions"Stablecoins" had the highest odds at 96% on Polymarket, followed by "Custodial” or “Custody” at 94% and “SEC” at 87%.Notably, Coinbase withdrew its support for the cryptocurrency market structure bill,  primarily due to a clause that p ...

Group 1 - Alphabet has sold bonds worth $20 billion in a seven-part offering [1] - The bonds have maturities extending out to 2066 [1] - The purpose of the bond sale is to fund the company's increasing spending on artificial intelligence infrastructure [1]

Achieved record high cryptocurrency treasury of 1,778 BTC and 3,951 ETH Deployed global hashrate exceeded 10 EH/s SINGAPORE, Feb. 10, 2026 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), an innovator in crypto mining, today released its unaudited bitcoin mining update for the month ending January 31, 2026. Management Commentary "Our results for January 2026 demonstrate the resilience and adaptability of our global mining operations," said Nangeng Zhang, chairman and CEO of Canaan. " ...

While reporting financial results for the fourth quarter on Tuesday, Wesco International, Inc. (WCC) initiated its adjusted earnings and revenue guidance for the full-year 2026.For fiscal 2026, the company projects adjusted earnings in a range of $14.50 to $16.50 per share on sales growth of 5 to 8 percent.On average, analysts polled expect the company to report earnings of $16.42 per share on revenue growth of 22.23 percent to $24.96 billion for the year. Analysts' estimates typically exclude special item ...

Fourth Quarter Highlights Full-Year Highlights Operational Highlights ® 2026 Full-Year Guidance CEO Commentary "Our fourth quarter and full-year results demonstrate the progress we are making in transforming the health care experience with our unique collection of businesses. From lowering drug prices, to improving navigation of health care, to being the front door of care across our country, we are well positioned to achieve our ambition to be the most trusted health care company in America." - David Joyne ...